Opinion · 2021
Conference abstractPublished 27 Oct 2016
Novel enzyme therapies for treatment of Cocaine addiction and overdose
University of Kentucky, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It has been known that cocaine produces the toxic and physiological effects through not only cocaine itself but also norcocaine formed from cocaine oxidation catalyzed by microsomal cytochrome P450 3A4 in the human liver. In addition, majority of cocaine users also consume alcohol, and alcohol can react with cocaine to produce cocaethylene which is significantly more cytotoxic than cocaine. Hence, a truly valuable cocaine-metabolizing enzyme for cocaine abuse/overdose treatment should be efficient for not only cocaine itself, but also its toxic metabolites including norcocaine and cocaethylene. The catalytic parameters (kcat and KM) of human butyrylcholinesterase (BChE) and various mutants (including the one which is under clinical trial for cocaine addiction treatment) for norcocaine and cocaethylene have been characterized in the present study in comparison with those for cocaine. Based on the obtained kinetic data, wild-type human BChE has a lower catalytic activity for norcocaine and cocaethylene compared to its catalytic activity for cocaine. The BChE mutants have considerably improved catalytic activity against norcocaine and cocaethylene compared to the wild-type BChE. One of the BChE mutants, denoted as E12-7, is identified as the most efficient enzyme for hydrolyzing norcocaine and cocaethylene in addition to its high activity for cocaine. E12-7 has a 2020-fold improved catalytic efficiency for cocaine, a 1080-fold improved catalytic efficiency for norcocaine, an 861-fold improved catalytic efficiency for cocaethylene, and a 10-fold improved catalytic efficiency for benzoylecgonine. It has been demonstrated that E12-7 as an exogenous enzyme can indeed rapidly metabolize cocaine, norcocaine and cocaethylene in rats.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 2021
Enhancement of Drug Overdose Deaths Involving Cocaine Abuse
Editorial · 2014
Novel Treatment Strategies for Cocaine and Opioid Abuse
Editorial · 26 Mar 2021
An Integrated Approach to Addressing Opioid Misuse, Addiction, and Overdose
Editorial · Jan 2013
The Thin Line to Prescribed Opioid Addiction, how to Identify and Prevent the Risk for the Deviant Behavior and Opioid Overdose
More from this journal
The newest in Drug Designing: Open Access.
Research article · 19 Aug 2025
Spectroscopic, Quantum Chemical, Molecular Docking Studies on Cellulose Acetate: Polyvinylidene Fluoride Blend Polymer Membrane for Wound Healing
Research article · 18 Apr 2025
Molecular Docking Studies on Polyphenols of Moringa oleifera for its Enhanced Production of Heamoglobin and Impact of its Extracts on Drosophila melanogaster
Opinion · 4 Mar 2025
Structure-Based Drug Design: Advances in Targeting Oncogenic Kinases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDrug Designing: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Fang Zheng”
- BylineArticles whose byline prints “Chang-Guo Zhan”

